drugset / Trial / NCT00718237
Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of the study is to evaluate whether V260 is effective and well tolerated in Japanese healthy infants.
Timeline
- Start
- 2008-08
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotarix | Vaccine | — | Oral |